Ci Private Wealth, LLC Outlook Therapeutics, Inc. Transaction History

Ci Private Wealth, LLC

  • $63.6 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023
BUY
$0.2 - $1.78 $6,800 - $60,520
34,000 Added 170.0%
54,000 $11,000
Q2 2023

Aug 10, 2023
SELL
$1.02 - $1.89 $29,580 - $54,810
-29,000 Reduced 59.18%
20,000 $34,000
Q1 2023

May 15, 2023
BUY
$1.0 - $1.35 $20,000 - $27,000
20,000 Added 68.97%
49,000 $53,000
Q4 2022

Feb 15, 2023
BUY
$0.87 - $1.33 $25,230 - $38,570
29,000 New
29,000 $31,000

Others Institutions Holding OTLK

# of Institutions
7
Shares Held
67.1K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.66B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email